BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS was delisted on the 6th of October, 2023.
30 hedge funds and large institutions have $135M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
2% more capital invested
Capital invested by funds: $132M → $135M (+$3.07M)
6% less funds holding
Funds holding: 32 → 30 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$7.29M |
| 2 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$5.6M |
| 3 |
BCM
BCK Capital Management
Stamford,
Connecticut
|
+$797K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$392K |
| 5 |
VF
Virtu Financial
New York
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QL
Quarry LP
New York
|
-$4.85M |
| 2 |
MSU
Mizuho Securities USA
New York
|
-$3.64M |
| 3 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$1.71M |
| 4 |
PCM
Prelude Capital Management
New York
|
-$1.6M |
| 5 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$1.06M |
BIOS Hedge Fund Activity: Q3 2023 in Review
30 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) for Q3 2023, worth a combined $135M — up 2.3% from $132M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIOS and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $7.29M. The largest seller was Quarry LP, exiting entirely with an estimated $4.85M sold.
- 30 institutional investors held BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) as of Q3 2023, down from 32 in Q2 2023.
- Funds reported $135M of BioPlus Acquisition Corp. Class A Ordinary Shares stock for Q3 2023, up 2.3% quarter-over-quarter.
- 4 funds opened new BioPlus Acquisition Corp. Class A Ordinary Shares positions in Q3 2023 and 6 closed out, a net change of -2 holders.
- The largest BioPlus Acquisition Corp. Class A Ordinary Shares buyer in Q3 2023 was Cowen and Company, an estimated $7.29M added.
- The largest BioPlus Acquisition Corp. Class A Ordinary Shares seller in Q3 2023 was Quarry LP, an estimated $4.85M sold.
Based on aggregated 13F filings for Q3 2023.